solanezumab effect healthy people carry genetic mutations high risk inheriting alzheimer rekindled hope monoclonal antibodies classes drugs earlier stages testing wind help alzheimer patients advanced stages development drugs targeting beta amyloid says heather snyder director medical scientific operations alzheimer association clinical trials targeting insulin tau inflammation mechanisms neuron growth health need identify biological changes taking place intervene treatments available medications lifestyle changes going reduce risk stop slow progression alzheimer article originally published title promise alzheimer drugs revived sa mind 26 6 10 11 november 2015 doi:10.1038 scientificamericanmind1115 10 4 hours ago robin lloyd | 7 hours ago tanya lewis josh